Submissions for Session Proposal Now Closed

Thank you for submitting session topics and speaker suggestions for the AusBiotech 2025 program. We are currently reviewing all proposals. For any enquiries, please contact events@ausbiotech.org.


For almost four decades, AusBiotech has united Australia’s life sciences sector, connecting people, ideas, and opportunities. Our flagship conference is the biggest week in biotech and life sciences, celebrating Australian life science innovations - from groundbreaking research to advanced medical technologies and therapies.  

As a super-connector event, it drives critical conversations within our industry, boosting collaboration, informing policy, and creating long-term partnerships that enable Australia’s life sciences ecosystem to thrive. 

Built by our industry for our industry, AusBiotech 2025 is a platform to showcase innovation, forge international partnerships, and shape the future of life sciences. The quality of submissions we receive each year reflects the sector’s groundbreaking advancements. We are currently reviewing this year’s proposals and curating a program that captures the topics and insights most relevant to our life sciences community.


Selection Criteria 

Proposals will be evaluated based on: 

  • Relevance: Alignment with current trends, research, and challenges in biotechnology and life sciences.

  • Originality: Novel approaches or fresh insights that stimulate thought and discussion. 

  • Applicability: Actionable knowledge that can be readily adopted or inform future collaborations.

  • Clarity: Well-organised and concise abstracts demonstrating rigour and impact. 


Please note: 

  • AusBiotech Conference in a cross disciplinary industry conference covering development in the life science industry rather than a scientific conference. Submissions will be considered by AusBiotech in respect to the overarching conference vision and will be assessed against current priorities in the industry.  

  • AusBiotech is committed to diversity and inclusion and submissions for panels will only be considered if they meet a 50% female representation threshold. 


We look forward to reviewing your submissions and welcoming your expertise at the AusBiotech International Conference 2025—where bold ideas, strategic alliances, and global innovation thrives.